Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker

Although serum galectin-1 antibodies (s-GAL-1-Abs) have been evaluated in a small number of patients with cancer, a large series of patients with different cancer types have not been reported. The current study evaluated 1,833 patients with esophageal cancer (n=172), gastric cancer (n=317), colorect...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanami, Tatsuki, Hoshino, Isamu, Shiratori, Fumiaki, Yajima, Satoshi, Oshima, Yoko, Suzuki, Takashi, Ito, Masaaki, Hiwasa, Takaki, Kuwajima, Akiko, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278395/
https://www.ncbi.nlm.nih.gov/pubmed/34276998
http://dx.doi.org/10.3892/mco.2021.2341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278395/
https://www.ncbi.nlm.nih.gov/pubmed/34276998
http://dx.doi.org/10.3892/mco.2021.2341

Ejemplares similares